好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

2024 Annual Meeting | C151 - Artificial Intelligence (AI) and the Neurologist: New Horizons

Wednesday 04/17/24
07:00 AM - 09:00 AM MDT Add To Calendar
This program will be presented both in-person and online
This program will be available in the meeting's On Demand product.
Seminar
Mark Mintz, MD, FAAN
Practice, Policy, and Ethics
Participants should gain an overall understanding of the types of AI and machine learning, learn about present and potential clinical applications of AI, and be introduced to the benefits and challenges that AI creates for neurologists.
 
This program is supported in part by an educational grant from Mylan Specialty L.P., a Viatris Company.
2.00 CME credits
Patient Care & Procedural Skills, Medical Knowledge, Systems-based Practice
Intermediate
Advanced Practice Provider, Artificial Intelligence
Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student, Business Administrator
Didactic, Audience Participation

Program Evaluations

Event Timeline
07:00 AM - 07:05 AM MDT Introduction AI: New Horizons
Mark Mintz, MD, FAAN
07:05 AM - 07:15 AM MDT Speaker How We Got Here
Sankar Bandyopadhyay, MD, FAAN
07:15 AM - 07:30 AM MDT Discussion Panel Discussion
Mark Mintz, MD, FAAN, Wesley Kerr, MD, PhD, Judith Dexheimer
07:30 AM - 07:40 AM MDT Speaker Current Applications
Wesley Kerr, MD, PhD
07:40 AM - 08:00 AM MDT Discussion Panel Discussion
Mark Mintz, MD, FAAN, Braydon Dymm, MD, Wesley Kerr, MD, PhD
08:00 AM - 08:10 AM MDT Speaker State of the Art Developments in AI
Judith Dexheimer
08:10 AM - 08:30 AM MDT Discussion Panel Discussion
Daniel Goldenholz, MD, PhD, Sankar Bandyopadhyay, MD, FAAN, Judith Dexheimer
08:30 AM - 08:40 AM MDT Speaker The Future
Daniel Goldenholz, MD, PhD
08:40 AM - 09:00 AM MDT Discussion Panel Discussion
Daniel Goldenholz, MD, PhD, Braydon Dymm, MD, Wesley Kerr, MD, PhD
Faculty Disclosures
Mark Mintz, MD, FAAN Dr. Mintz has nothing to disclose.
Daniel Goldenholz, MD, PhD Dr. Goldenholz has received personal compensation in the range of $0-$499 for serving as a Consultant for Neuro Event Labs. Dr. Goldenholz has received personal compensation in the range of $0-$499 for serving as a Consultant for IDR. Dr. Goldenholz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Livanova . Dr. Goldenholz has received personal compensation in the range of $0-$499 for serving as a Consultant for Health Advances . Dr. Goldenholz has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AAN. Dr. Goldenholz has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for ACNS. Dr. Goldenholz has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AES. Dr. Goldenholz has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Nebraska Neurological Society . The institution of Dr. Goldenholz has received research support from NIH. The institution of Dr. Goldenholz has received research support from BIDMC. Dr. Goldenholz has a non-compensated relationship as a advisor with Eysz that is relevant to AAN interests or activities. Dr. Goldenholz has a non-compensated relationship as a advisor with Epilepsy AI that is relevant to AAN interests or activities.
Braydon Dymm, MD Dr. Dymm has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AvoMD. Dr. Dymm has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Glass Health.
Sankar Bandyopadhyay, MD, FAAN Dr. Bandyopadhyay has nothing to disclose.
Wesley Kerr, MD, PhD Dr. Kerr has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for SK Lifesciences. Dr. Kerr has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven Pharmaceuticals. Dr. Kerr has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EpiTel. Dr. Kerr has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Kerr has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurelis. Dr. Kerr has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven Pharmaceuticals. Dr. Kerr has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cerebral Therapeutics. Dr. Kerr has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Epilepsia. The institution of Dr. Kerr has received research support from NINDS. The institution of Dr. Kerr has received research support from American Epilepsy Society. The institution of Dr. Kerr has received research support from 好色先生. Dr. Kerr has received publishing royalties from a publication relating to health care.
Judith Dexheimer No disclosure on file